High prevalence of HBV, HCV, and HIV infections in gypsy population residing Shahr-e-Kord

Archives of Iranian Medicine

Volumn 7, Issue 1, 2004, Pages 20-22

  Hosseini Asl, Seyyed Kazem ^a   Avijgan, Majid ^a,c   Mohamadnejad, Mehdi ^b  

^a SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c NONE   (Iran)

Author keywords

Acquired immunodeficiency syndrome; Gypsy; Hepatitis B virus; Hepatitis C virus; Iran; Prevalence

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GIPSY; HEALTH PROMOTION; HEPATITIS B; HEPATITIS C; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; INFANT; IRAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROPHYLAXIS; SEROLOGY; VACCINATION;

EID: 3042569491     PISSN: 10292977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Robinsin WS. Hepatitis B virus and hepatitis D virus. In: Mandell GL, Benette JE, Dolin R, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 5th ed. Vol 2. Philadelphia: Churchill Livingstone; 2000: 1652 - 68.
2. Vitro Ruiz MT, Marin Alcala MP, Pascual Val T, Lopez Morras C, Aramburu Bergua I, Zubicoa Ventura J. Endemic hepatitis B in 2 marginal ethnic minorities. Comparative study [in Spanish]. Med Clin (Barc). 1993; 101: 245 - 8.
3. No Authors listed. Seroprevalance of hepatitis C virus infection at the time of entry to prison in the prison population in the North-East of Spain [in Spanish]. Rev Esp Salud Publica. 1998; 72: 43 - 51.
4. Teira R, Lizzaralde E, Munoz P, Zubero Z, Baraiaetxaburu J, Sentamaria JM. A cross-sectional study on the epidemiological and clinical characteristics of HIV-1 infection in gypsies and in other minorities in Bilbao, northern Spain [in Spanish]. Med Clin (Barc). 2002; 119: 653 - 6.
5. Malekzadeh R, Khatibian M, Rezvan H. Viral hepatitis in the world and Iran [in Persian]. J Iranian Med Council. 1997; 15: 183 - 200.
6. Adibi P, Mohammad K, Zali MR. Effect of hepatitis B vaccination on vaccinated and nonvaccinated children in Iran [in Persian]. Govaresh. 2003; 42: 209 - 10.
7. Massarrat MS, Tahaghoghi-Mehrizi S. Iranian national health survey: a brief report. Arch Iranian Med. 2002; 5: 73 - 9.
8. Pourshams A, Malekzadeh R, Monavvari A. Prevalence and etiology of persistently elevated alanine aminotransferase levels in healthy Iranian blood donors. J Gastroenterol Hepatol [In press].
9. Alavian SM, Gholami B, Masarrat S. Hepatitis C risk factors in Iranian volunteer blood donors: a case-control study. J Gastroenterol Hepatol. 2002; 17: 1092 - 7.
10. Tindall B, Cooper DA, Donovan B, Penny R. Primary human immunodeficiency virus infection. Clinical and serologic aspects. Infect Dis Clin North Am. 1988; 2: 329 - 41.
11. McQuillan G, Alter M, Moyer L. A population based serologic study of hepatitis C virus infection in the United States. Proceedings of the IX International Symposium on Viral Hepatitis and Liver Disease, Rome, Italy; 1996: 8A.
12. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med. 1999; 341: 556 - 62.
13. Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med. 1997; 336: 1855 - 9.